Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical-devices: Archive
GE HealthCare's (GEHC) Voluson to Aid Women's Health Imaging
by Zacks Equity Research
GE HealthCare (GEHC) announces its latest AI-powered Voluson Signature 20 and 18 ultrasound systems, which are likely to provide effective and efficient care for conditions impacting women's health.
DVANegative Net Change CAHPositive Net Change CORPositive Net Change GEHCPositive Net Change
medical medical-devices
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
by Zacks Equity Research
AtriCure (ATRC) unveils its cryoSPHERE+ cryoablation probe, which is intended to reduce freeze times and aid in postoperative pain management.
DVANegative Net Change CAHPositive Net Change LMATNegative Net Change ATRCNegative Net Change
medical medical-devices
Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement in margins buoys well.
ISRGNegative Net Change DVANegative Net Change CAHPositive Net Change CORPositive Net Change
earnings medical medical-devices
What Lies Ahead of IDEXX Laboratories (IDXX) in Q1 Earnings?
by Zacks Equity Research
IDEXX Laboratories' (IDXX) first-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.
IDXXPositive Net Change PODDNegative Net Change INSPPositive Net Change TMDXNegative Net Change
earnings medical medical-devices
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
by Nalak Das
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
LHNegative Net Change UHSPositive Net Change EWPositive Net Change HCANegative Net Change PODDNegative Net Change
medical medical-devices
Here's Why You Should Retain Prestige Consumer (PBH) Stock Now
by Zacks Equity Research
The robust strength of Prestige Consumer's (PBH) diversified portfolio bodes well for investors.
PBHNegative Net Change PODDNegative Net Change EXASNegative Net Change INSPPositive Net Change
medical medical-devices
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
by Benjamin Rains
Long-term investors are often well-served to buy stocks amid bouts of weakness.
ALGNPositive Net Change DXCMPositive Net Change VRTPositive Net Change
medical-devices tech-stocks
Big Q1 Beats After the Close; Markets Struggle to Gain
by Mark Vickery
Netflix, Taiwan Semi and Intuitive Surgical all handily beat Q1 estimates, but only one is trading in the green this afternoon.
NFLXNegative Net Change ISRGNegative Net Change TSMNegative Net Change
earnings medical-devices tech-stocks
Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
by Zacks Equity Research
Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
ECLPositive Net Change DVANegative Net Change CORPositive Net Change OMPositive Net Change
medical medical-devices
Big-Picture Investing as Q1 Earnings Loom: Stocks to Watch
by Bryan Hayes
The earnings slate is set to heat up in the coming days.
NFLXNegative Net Change ISRGNegative Net Change
ad-tech advertising artificial-intelligence consumer-discretionary earnings investing media medical medical-devices tech-stocks
Why You Should Add Inspire Medical (INSP) to Your Portfolio
by Zacks Equity Research
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
ECLPositive Net Change DVANegative Net Change CORPositive Net Change INSPPositive Net Change
medical medical-devices
Here's Why You Should Retain Medtronic (MDT) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.
MDTNegative Net Change DVANegative Net Change CAHPositive Net Change LMATNegative Net Change
medical medical-devices
IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA
by Zacks Equity Research
IceCure Medical (ICCM) submits final ICE data along with multiple sub-analysis to the FDA seeking approval for marketing authorization for treating early-stage breast cancer.
DVANegative Net Change CAHPositive Net Change CORPositive Net Change ICCMNo Net Change
medical medical-devices
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
by Zacks Equity Research
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
EWPositive Net Change BIONegative Net Change SWAVPositive Net Change HITINegative Net Change
earnings medical medical-devices
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
by Zacks Equity Research
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DVANegative Net Change DXCMPositive Net Change CORPositive Net Change BDSXNegative Net Change
medical medical-devices
CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
The strength of a diversified enterprise, along with robust operational execution, is expected to be reflected in CVS Health's (CVS) first-quarter 2024 results.
CVSNegative Net Change PODDNegative Net Change INSPPositive Net Change TMDXNegative Net Change
earnings medical medical-devices
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
by Zacks Equity Research
PacBio's (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.
ECLPositive Net Change DVANegative Net Change CORPositive Net Change PACBNegative Net Change
medical medical-devices
Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
EWPositive Net Change HOLXNegative Net Change SWAVPositive Net Change HITINegative Net Change
earnings medical medical-devices
GE HealthCare (GEHC), RSNA Unite to Aid Breast Cancer Imaging
by Zacks Equity Research
GE HealthCare (GEHC) and RSNA collaborate to provide radiologists at Muhimbili National Hospital a test mammography technology and advanced imaging training to aid in the treatment of breast cancer.
DVANegative Net Change CAHPositive Net Change CORPositive Net Change GEHCPositive Net Change
medical medical-devices
Here's Why You Should Retain Chemed (CHE) Stock for Now
by Zacks Equity Research
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
SYKPositive Net Change DVANegative Net Change CORPositive Net Change CHEPositive Net Change
medical medical-devices
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
by Zacks Equity Research
Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
ABTNegative Net Change PODDNegative Net Change EXASNegative Net Change INSPPositive Net Change
earnings medical medical-devices
Here's Why You Should Retain Henry Schein (HSIC) Stock for Now
by Zacks Equity Research
Favorable Dental business trends and expansion efforts through acquisitions and partnerships bode well for Henry Schein (HSIC).
HSICPositive Net Change PODDNegative Net Change EXASNegative Net Change INSPPositive Net Change
medical medical-devices
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
by Zacks Equity Research
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
DVANegative Net Change CORPositive Net Change WSTNegative Net Change BDSXNegative Net Change
medical medical-devices
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
by Zacks Equity Research
Masimo's (MASI) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.
AAPLPositive Net Change DVANegative Net Change MASINegative Net Change BDSXNegative Net Change
medical medical-devices
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.
ISRGNegative Net Change EWPositive Net Change MASINegative Net Change SIBNNegative Net Change
medical medical-devices